CLINICAL ANALYSIS AND MANAGEMENT OF RHINO-ORBITO-CEREBRAL MUCORMYCOSIS IN 2ND WAVE OF COVID-19 IN TERTIARY CARE CENTRE
PRAJAKTA PATIL
Department of Ophthalmology, Krishna Institute of Medical Sciences, KIMSDU, Karad, India.
DEVIKA DAMLE *
Department of Ophthalmology, Krishna Institute of Medical Sciences, KIMSDU, Karad, India.
SUPRIYA BHAVAKE
Department of Ophthalmology, Krishna Institute of Medical Sciences, KIMSDU, Karad, India.
SANVEDYA KADAM
Department of Ophthalmology, Krishna Institute of Medical Sciences, KIMSDU, Karad, India.
*Author to whom correspondence should be addressed.
Abstract
The present study mainly deals with the patients manifesting with mucormycosis (BLACK FUNGUS) in 2ND Wave of COVID-19 patients. Rhino-orbito-cerebral ucormycosis is an uncommon infection caused by the angiotropic fungus belonging to the order Mucorales. The study involves case series of 14 patients with average age group from 35 to 65 years showing male predominance diagnosed and treated with rhino-orbital-cerebral mucormycosis in COVID-19 in Krishna hospital, Karad from April 2021 to May 2021. The symptoms of rhino-orbital cerebral mucormycosis are often non-specific with varying spectrum and severity. All patients studied in this series were non vaccinated for COVID-19. Post vaccination presentation of mucormycosis warrants further study. Hence, early diagnosis and prompt treatment can reduce the mortality and morbidity of this lethal fungal infection.
Keywords: Black fungus, vaccination, Rhino-orbito-cerebral mucormycosis, COVID-19